GlassScriptPhysician profile
Abdul Tariq
NPI 1669883534
$8,776.76
in general payments reported to CMS, 2019-2025
48 companies · $2,360 in 2025
The $2,360 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $244 · 2021: $350 · 2022: $633 · 2023: $2,347 · 2024: $1,939 · 2025: $2,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,647.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,191.68 | 2021-2025 | Ubrelvy, Botox, Duopa |
| Novartis Pharmaceuticals Corporation | $880.63 | 2019-2025 | |
| Ucb, INC. | $785.75 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Biogen, INC. | $746.34 | 2019-2025 | Vumerity, Tysabri |
| Neurocrine Biosciences, INC. | $590.44 | 2022-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $590.31 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Genentech USA, INC. | $445.85 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Alexion Pharmaceuticals, INC. | $314.64 | 2022-2025 | Ultomiris, Soliris |
| Celgene Corporation | $233.15 | 2023-2025 | Zeposia |
| Genzyme Corporation | $221.07 | 2019 | |
| Amgen INC. | $218.47 | 2019-2024 | Uplizna |
| Emd Serono, INC. | $197.83 | 2023-2024 | Mavenclad |
| Sk Life Science, INC. | $160.62 | 2023-2025 | Xcopri |
| Corium, LLC | $155.61 | 2023 | Adlarity |
| Eisai INC. | $154.87 | 2023-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Tariq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.